Related Experiment Video
Updated: Mar 3, 2026

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
Published on: July 24, 2013
Frailty and Cognitive Function After the Age of 40 in Adults With Moderate or Severe Congenital Heart Disease
Sandra Skogby1,2, Christina Christersson3, Joanna Hlebowicz4
1Department of Diagnostics and Intervention, Umeå University, Umeå, Sweden.
Insights
Adults with congenital heart disease (CHD) show similar rates of frailty and cognitive dysfunction compared to controls. Further research is needed as more CHD patients age.
Area of Science:
- Cardiology
- Geriatrics
- Neurology
Background:
- Advances in congenital heart disease (CHD) care shift focus to long-term outcomes and aging.
- Understanding the aging process in adults with CHD is crucial for maintaining quality of life.
- This study investigates frailty and cognitive function in aging adults with CHD.
Purpose of the Study:
- To compare the prevalence of frailty and cognitive dysfunction in adults with CHD versus a control group.
- To assess the long-term health implications for the growing population of adults with CHD.
- To inform interventions for safeguarding quality of life in aging adults with CHD.
Main Methods:
- A multicenter study compared adults (≥40 years) with moderate/complex CHD to age- and sex-matched controls.
- Frailty was assessed using the Fried method.
- Cognitive function was evaluated with the Montreal Cognitive Assessment tool.
Main Results:
- No significant difference in Montreal Cognitive Assessment scores between adults with CHD and controls (27.1 vs 26.9, P=0.59).
- Similar prevalence of prefrailty/frailty was observed in both groups (36.5% vs 29.0%, P=0.26).
- The study included 156 adults with CHD and 86 controls.
Conclusions:
- Cognitive dysfunction and frailty prevalence rates are comparable between adults with CHD and age-matched controls.
- Future research should monitor these outcomes as CHD populations age, especially those with complex conditions.
- Long-term prognosis and quality of life for aging adults with CHD require ongoing investigation.
Background:
Decades of progress in care and treatment for congenital heart disease (CHD) has gradually shifted the research focus from initial survival to long-term prognosis and the ageing of adults with CHD. Knowledge about the ageing adult with CHD will guide interventions to safeguard the quality of life across the life course. The present study compares the prevalence of frailty and cognitive dysfunction between adults with CHD and a control group.
Methods:
Using a multicentre design, we compared adults with moderate or complex CHD aged ≥40 years, equally distributed across the age groups 40-49, 50-59, and >60 years, with age- and sex-matched controls. We assessed frailty phenotypes using the Fried method and cognitive dysfunction using the Montreal Cognitive Assessment tool.
Results:
In total, 156 adults with CHD (56.0 ± 10.4 years, 54.4% male) and 86 controls (55.6 ± 11.2 years, 55.8% male) were included in the study. Adults with CHD and controls did not differ in terms of mean score on the Montreal Cognitive Assessment (mean score 27.1 vs 26.9, P = 0.59). Similarly, there was no statistical difference in the prevalence of prefrailty/frailty between adults with CHD and controls (36.5% vs 29.0%, P = 0.26).
Conclusions:
Prevalence rates of cognitive dysfunction and frailty were similar between adults with CHD and age-matched controls. As more patients, particularly those with complex heart lesions, reach older ages, the prevalence of cognitive impairment and frailty may change.
Related Concept Videos
Cognitive Development During Adulthood
Heart Failure II: Pathophysiology
Heart Failure III: Clinical Manifestations
Heart Failure I: Introduction
Pharmacodynamics in Geriatric Patients: Effects of Age
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...

